Repligen (RGEN) Total Non-Current Liabilities (2011 - 2026)

Repligen's (RGEN) quarterly Total Non-Current Liabilities came in at $808.6 million in Q1 2026, up 13.14% year-on-year from $714.7 million in Q1 2025, and up 14.24% on a QoQ basis from $707.7 million in Q4 2025.

Repligen (RGEN) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

Repligen (RGEN) has 16 years of Total Non-Current Liabilities data on file, last reported at $808.6 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 13.14% year-over-year to $808.6 million in Q1 2026; TTM through Mar 2026 was $808.6 million, a 13.14% increase from a year earlier, with the FY2025 full-year figure at $707.7 million, down 3.07% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $808.6 million, up from $707.7 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for RGEN reached as high as $808.6 million in Q1 2026 and fell as low as $170.1 million in Q3 2023.
  • Historically, Total Non-Current Liabilities has averaged $508.1 million across 5 years, with a median of $705.6 million in 2024.
  • Across the five-year window, Total Non-Current Liabilities retreated 21.54% in 2023 and surged 314.93% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $216.7 million in 2022, then soared by 223.67% to $701.4 million in 2023, then advanced by 4.1% to $730.2 million in 2024, then dropped by 3.07% to $707.7 million in 2025, then climbed by 14.24% to $808.6 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $808.6 million in Q1 2026, $707.7 million in Q4 2025, and $709.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 6.48 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 1.92 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 48.37 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 17.13 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 941.16 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 996.30 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 4.24 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 8.65 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 2.06 Bn
10 Repligen 7.75 Bn 6.77 Bn 108.28 Mn 808.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 808.55 Mn
Dec 31, 2025 707.74 Mn
Sep 30, 2025 709.49 Mn
Jun 30, 2025 716.87 Mn
Mar 31, 2025 714.66 Mn
Dec 31, 2024 730.16 Mn
Sep 30, 2024 705.59 Mn
Jun 30, 2024 706.76 Mn
Mar 31, 2024 706.55 Mn
Dec 31, 2023 701.40 Mn
Sep 30, 2023 170.05 Mn
Jun 30, 2023 211.85 Mn
Mar 31, 2023 204.67 Mn
Dec 31, 2022 216.70 Mn
Sep 30, 2022 216.73 Mn
Jun 30, 2022 216.03 Mn
Mar 31, 2022 193.09 Mn
Dec 31, 2021 233.03 Mn
Sep 30, 2021 176.69 Mn
Jun 30, 2021 80.55 Mn